Sollte ich retinoyl pentapeptide-4 in der Schwangerschaft meiden? | VeriMom

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

Ist retinoyl pentapeptide-4 in der Schwangerschaft sicher?

No evidence in EU Cosmetics Annex II/III or harmonised CLP of reproductive hazards for palmitoyl pentapeptide‑4; regulatory/industry sources and ingredient databases list it as a signal peptide (Matrixyl) with no reproductive or teratogenic classification. Topical peptides have low but measurable dermal absorption, and palmitoyl conjugation increases lipophilicity and skin penetration modestly, so exposure is low but measurable in adults. Sources: EWG ingredient page; ingredient summaries (Paula's Choice) and peptide safety overview (CIR pentapeptides review).

Ist retinoyl pentapeptide-4 während des Stillens sicher?

Same rationale as pregnancy: no CMR or reproductive classifications and no published animal/human developmental or lactation toxicity for palmitoyl pentapeptide‑4. Topical exposure to parent peptide is low but measurable; transfer into breastmilk not reported. Evidence absence supports low hazard. (See same sources.)

Ist retinoyl pentapeptide-4 sicher für Babyhaut?

No infant‑specific developmental or toxicity data were found. Because infant/young‑child skin has higher absorption (higher surface‑area:weight and immature barrier), increase exposure score by +1 over adult (adult e=1 → infant e=2). No data indicate increased hazard or specific mechanisms affecting development or endocrine systems for this peptide. Sources: peptide safety reviews and product/INCI descriptions.

Wie bewertet VeriMom retinoyl pentapeptide-4?

VeriMom bewertet retinoyl pentapeptide-4 mit 13/100 (hohes Risiko) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.

Was sind schwangerschaftssichere Alternativen zu retinoyl pentapeptide-4?

Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu retinoyl pentapeptide-4 basierend auf ähnlicher Funktion.